Current insights into the roles of miRNAs, lncRNAs, and chromatin modifiers in Parkinson’s disease are critically summarized, their potential as biomarkers and therapeutic targets are discussed, and key challenges and future perspectives in translating epigenetic discoveries into clinical applications are highlighted.
Sumithira George, Sivakumar Subramaniyan, Mukesh Rajagopal et al.· Scholars Journal of Applied...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.